Taiwan · Delayed Price · Currency is TWD Chunghwa Chemical Synthesis & Biotech Company Description
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacturing, sale, and wholesale of western medicine in Taiwan and internationally.
The company offers biotechnology products, including Anidulafungin antifungal medication, Caspofungin Acetate antifungal medication, Dalbavancin Hydrochloride Bacterial Skin Infection Drug, Everolimus, immunosuppressant and anticancer drug), Midostaurin for treating acute myeloid leukemia, Pneumocandin B0 antifungal intermediate, Rapamycin, Rezafungin acetate antifungal medication, Semaglutide weight loss medication, and Tacrolimus immunosuppressant, as well as Mycophenolate Mofetil, Mycophenolate Mofetil HCl, and Mycophenolate Sodium immunosuppressive drugs.
It also provides non-biotechnology products, such as Abaloparatide osteoporosis medication, Baricitinib rheumatoid arthritis medication, Brivaracetam antiepileptic drug, Difelikefalin Acetate Pruritus, Edoxaban Tosylate Monohydrate, Eltrombopag Olamine, Eslicarbazepine Actate, Ethyl Icosapentate, Lanreotide Acetateacromegaly), Ozanimod HCl medicine for multiple sclerosis, Ribociclib for breast cancer medication, Plecanatide chronic idiopathic constipation medication, Ribociclib breast cancer medication, Selumetinib Sulfate for neurofibromatosis, Setmelanotide Acetate genetic obesity drug, Sugammadex Sodium anesthesia recovery medication, Tofacitinib Citrate rheumatoid arthritis medication, Trandolapril antihypertensive medication, Trilaciclib Dihydrochloride bone marrow protectant, Tenapanor HCl medication for constipation-predominant irritable bowel syndrome and hyperphosphatemia in dialysis patients.
The company was formerly known as China Chemical Synthesis Industry Co., Ltd. and changed its name to Chunghwa Chemical Synthesis & Biotech Co., Ltd. in January 2003.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
| Country | Taiwan |
| Founded | 1964 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 198 |
| CEO | Qing-Peng Wei |
Contact Details
Address: 1, Tung-Hsing St. New Taipei City, 23850 Taiwan | |
| Phone | 886 2 8684 3318 |
| Website | ccsb.com.tw |
Stock Details
| Ticker Symbol | 1762 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0001762003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Qing-Peng Wei | General Manager |
| Kuan-Chieh Wang | Manager of Finance Department and Head of Corporate Governance |
| Guanjie Wang | Accounting Supervisor |
| Jun-Jie Liao | Manager of Human Resource Office |
| Chao-Sheng Hong | Chief Auditor |